Immunotherapy Plus Chemoradiotherapy Triples Survival in Esophageal Cancer Study
A propensity score matched study from Taiwan finds that adding the immunotherapy drug nivolumab to definitive chemoradiotherapy tripled median overall ...
Tag: Progression-Free Survival
Brain Surgery’s Most Feared Side Effect May Not Shorten Glioma Patients’ Lives
A Munich study of 74 glioma patients found that postoperative supplementary motor area syndrome, despite affecting half of those operated ...
When Chemotherapy Triggers Bleeding: A Warning Sign in Gut Lymphoma
A propensity-score matched study finds that gastrointestinal bleeding after first-line chemotherapy in gastrointestinal diffuse large B-cell lymphoma signals sharply worse ...
Surufatinib Plus Immunotherapy Shows Promise as Maintenance Therapy for Aggressive Lung Cancer
A phase 2a trial found that surufatinib combined with PD-1/PD-L1 inhibitors as first-line maintenance therapy yielded a median progression-free survival ...
Blood Group O Linked to Longer Survival in MGMT-Methylated Glioblastoma Patients
A retrospective study at University Hospital Bonn independently confirms that blood group O is associated with significantly longer progression-free and ...
Pancreatic Cancers With ATM Defects May Respond to Irinotecan, Study Finds
A new study combining real-world clinical data with CRISPR-edited cell models shows that pancreatic cancers with ATM or CHEK2 mutations ...
Kidney Damage Doesn’t Rule Out Transplants for Myeloma Patients, Brazilian Study Shows
A Brazilian study of 53 myeloma patients with renal impairment shows autologous stem cell transplantation carries high toxicity and intensive ...
Morning infusions may boost immunotherapy survival benefit, major analysis finds
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
Protein Maps of Colorectal Cancer Reveal New Biomarkers of Tumor Spread
A detailed proteomic study of colorectal cancer tumors has identified more than 12,000 proteins and a set of candidate biomarkers ...
Blood Test Tracks Early Response to Breast Cancer Drug Eribulin in Landmark Trial
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!